Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Parental Notions and Clinical Experiences About Child's Gut Comfort, Overall Satisfaction and Sense of Well-being When Consuming a New Toddler Milk

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04768933
Recruitment Status : Completed
First Posted : February 24, 2021
Last Update Posted : February 24, 2021
Sponsor:
Information provided by (Responsible Party):
Nestlé

Brief Summary:
This is a prospective, open-label, single-arm study in a real-world setting of healthy Chinese toddlers provided with new toddler milk for a total of 4 weeks (28 days).

Condition or disease Intervention/treatment Phase
Digestion Happiness Temperament Dietary Supplement: Toddler Milk Not Applicable

Detailed Description:
The new toddler milk contains prebiotic and an optimized fat blend of bovine milk fat, vegetable fats, and a LC-PUFA oil mixture (providing DHA and ARA). The prebiotic and bovine milk fat-based blend have shown to be able to improve digestive comfort and milk taste. Physiological factors such as physical discomfort has been shown to be associated with negative emotionality and temperament (Putnam 2012). Therefore, the investigators hypothesize that by improving digestive comfort, they are able to influence child temperament, happiness, and other behavioral characteristics.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 100 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Parental Notions and Clinical Experiences About Child's Gut Comfort, Overall Satisfaction and Sense of Well-being When Consuming a New Toddler Milk
Actual Study Start Date : October 11, 2020
Actual Primary Completion Date : November 28, 2020
Actual Study Completion Date : December 12, 2020

Arm Intervention/treatment
Experimental: Toddler Milk Group
All enrolled subjects with be provided a new toddler milk for 28 days. Aligned with clinical and label recommendations, they will be required to intake at least 3 servings of 130 ml per day.
Dietary Supplement: Toddler Milk
At least three 130 mL servings daily of study formula are recommended for a total daily intake of 390 mL. Study participants will continue this feeding regimen Days 4 to 28 (approximately 4 weeks).




Primary Outcome Measures :
  1. Digestive tolerance [ Time Frame: Baseline (week 0) and week 4 (Day 28±2) ]
    Change in overall digestive tolerance composite scores measured by the Toddler Gut Comfort Questionnaire consisting of 10 questions on parent perceptions of constipation, diarrhea, gassiness, abdominal pain, bloating and other GI-related behaviors.


Secondary Outcome Measures :
  1. Temperament [ Time Frame: from baseline (week 0) to week 4 (Day 28±2) ]
    Change in temperament surgency scores derived from the Children's Behavior Questionnaire (CBQ), short version

  2. Child's emotional expressions [ Time Frame: at weeks 0 (baseline), 1 (Day 7±2), 2 (Day 14±2), and 4 (Day 28±2). ]
    Child's emotional expressions such as Happy, Smiling, Surprised, Anger, and Disgust derived from the Anura phone app. In addition, parents will report child's mood including being happy, relaxed and smiling in the Mood Diary.

  3. Milk Satisfaction [ Time Frame: at weeks 0 (baseline), 1 (Day 7±2) and 4 (Day 28±2). ]
    Milk Satisfaction derived from a toddler and parent-reported brief (9-items) Milk Satisfaction Questionnaire The questionnaire consists of questions regarding taste, sweetness, milky taste, nutritional profile, and convenience.

  4. Weight in kilograms [ Time Frame: at week 0 (baseline) and week 4 (Day 28±2) ]
    Weight (kg) will be taken for the purpose of assessing child's growth

  5. Height in centimeters [ Time Frame: at week 0 (baseline) and week 4 (Day 28±2) ]
    Height (cm) will be taken for the purpose of assessing child's growth

  6. Milk intake [ Time Frame: at baseline and prospectively during transition period (Day 1-3) and for three consecutive days on week 1 (Day 7±2), 2 (Day 14±2) and 4 (Day 28±2). ]
    based on 24-hour recall of dairy and non-dairy intake obtained from the Milk Intake Questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Months to 33 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Generally healthy toddlers born at term (37-42 weeks of gestation).
  2. At enrolment visit, toddler age 12-33 months.
  3. Birth weight ≥ 2500g and ≤ 4500g.
  4. No known milk intolerance / allergies to cow's milk protein.
  5. Habitually consuming some cow's milk or other traditional milks.

Exclusion Criteria:

  1. Toddler is currently breastfed or is consuming breast milk.
  2. Toddler who is experiencing growth faltering (defined as weight for length z score ≤-1.67).
  3. History of preterm birth
  4. Currently experiencing severe constipation.
  5. Currently diagnosed with other Functional Gastrointestinal Disorders.
  6. Toddlers who have known cognitive and developmental disorders.
  7. Toddlers who are currently participating in or have participated in another clinical trial within 4 weeks prior to trial start.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04768933


Locations
Layout table for location information
China
Shanghai China-norm Information Technology co., LTD
Shanghai, China, 200000
Sponsors and Collaborators
Nestlé
Layout table for additonal information
Responsible Party: Nestlé
ClinicalTrials.gov Identifier: NCT04768933    
Other Study ID Numbers: 20.14.INF
First Posted: February 24, 2021    Key Record Dates
Last Update Posted: February 24, 2021
Last Verified: February 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Nestlé:
prebiotic
digestion
child development
temperament